R
Relavo has developed the PeritoneX™, an in-line connection device that disinfects dialysis tubes at all connection sites, significantly reducing the risk of peritonitis in patients undergoing peritoneal dialysis. This technology addresses the high infection rates associated with home dialysis, which affect nearly 30% of patients annually and often lead to hospitalization.
Updated 20 months ago
Funding
$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BXFunding rounds are not available yet.
Founders
Product
Features
- Relavo has developed the PeritoneX™, an in-line connection device that disinfects dialysis tubes at all connection sites, significantly reducing the risk of peritonitis in patients undergoing peritoneal dialysis. This technology addresses the high infection rates associated with home dialysis, which affect nearly 30% of patients annually and often lead to hospitalization.